Poolbeg Pharma’s Phase 2a TOPICAL trial is investigating whether POLB [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]

Poolbeg Pharma has received a decision to grant a European [...]

Poolbeg Pharma has presented two posters at the European Hematology [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]